These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9140121)

  • 1. Characterization of residual tumor cells following radical radiation therapy for prostatic adenocarcinoma; immunohistochemical expression of prostate-specific antigen, prostatic acid phosphatase, and cytokeratin 8.
    Ljung G; Norberg M; Holmberg L; Busch C; Nilsson S
    Prostate; 1997 May; 31(2):91-7. PubMed ID: 9140121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of PAP and PSA gene expression in prostatic hyperplasia and prostatic carcinoma using northern-blot analyses, in situ hybridization and immunohistochemical stainings with monoclonal and bispecific antibodies.
    Hakalahti L; Vihko P; Henttu P; Autio-Harmainen H; Soini Y; Vihko R
    Int J Cancer; 1993 Oct; 55(4):590-7. PubMed ID: 7691762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in immunohistochemical staining of PSA, PAP, and TURP-27 following irradiation therapy for clinically localized prostate cancer.
    Grob BM; Schellhammer PF; Brassil DN; Wright GL
    Urology; 1994 Oct; 44(4):525-9. PubMed ID: 7524238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: a novel prostate cancer marker.
    Darson MF; Pacelli A; Roche P; Rittenhouse HG; Wolfert RL; Young CY; Klee GG; Tindall DJ; Bostwick DG
    Urology; 1997 Jun; 49(6):857-62. PubMed ID: 9187691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate-specific antigen in the follow-up of prostatic adenocarcinoma treated with external beam radiation.
    Kellokumpu-Lehtinen P; Nurmi M; Koskinen P; Irjala K
    Urol Int; 1991; 46(1):6-8. PubMed ID: 1708923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relation of prostatic acid phosphatase and prostate specific antigen with tumour grade in prostatic adenocarcinoma: an immunohistochemical study.
    Ersev A; Ersev D; Turkeri L; Ilker Y; Simsek F; Kullu S; Akdas A
    Prog Clin Biol Res; 1990; 357():129-34. PubMed ID: 1699237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate-specific antigen, high-molecular-weight cytokeratin (clone 34betaE12), and/or p63: an optimal immunohistochemical panel to distinguish poorly differentiated prostate adenocarcinoma from urothelial carcinoma.
    Kunju LP; Mehra R; Snyder M; Shah RB
    Am J Clin Pathol; 2006 May; 125(5):675-81. PubMed ID: 16707367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinical and immunohistochemical study of papillary adenocarcinoma of the prostate.
    Ito T; Furusato M; Akiyama A; Kato H; Aizawa S
    Prostate; 1995 Jan; 26(1):23-7. PubMed ID: 7531325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate.
    Stamey TA; Yang N; Hay AR; McNeal JE; Freiha FS; Redwine E
    N Engl J Med; 1987 Oct; 317(15):909-16. PubMed ID: 2442609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steroids inversely affect the biosynthesis and secretion of human prostatic acid phosphatase and prostate-specific antigen in the LNCaP cell line.
    Henttu P; Vihko P
    J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):349-60. PubMed ID: 1373297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate specific antigen and prostatic acid phosphatase immunoreactivity as prognostic indicators of advanced prostatic carcinoma.
    Sakai H; Yogi Y; Minami Y; Yushita Y; Kanetake H; Saito Y
    J Urol; 1993 May; 149(5):1020-3. PubMed ID: 7683340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical demonstration of tumor-associated antigens in prostatic carcinomas of various histological differentiations.
    Friedmann W; Steffens J; Lobeck H; Blümcke S; Nagel R
    Eur Urol; 1985; 11(1):52-6. PubMed ID: 2580711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases.
    Bostwick DG; Pacelli A; Blute M; Roche P; Murphy GP
    Cancer; 1998 Jun; 82(11):2256-61. PubMed ID: 9610707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate-specific antigen as a marker of adenocarcinoma of prostate.
    Kellokumpu-Lehtinen P; Nurmi M; Koskinen P; Irjala K
    Urol Res; 1989; 17(4):245-9. PubMed ID: 2475959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
    Sheridan T; Herawi M; Epstein JI; Illei PB
    Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate inhibin peptide (PIP) in prostate cancer: a comparative immunohistochemical study with prostate-specific antigen (PSA) and prostatic acid phosphatase (PAP).
    Garde SV; Sheth AR; Venkatesan VM; Panchal CJ; Porter AT; Grignon DJ
    Cancer Lett; 1994 Apr; 78(1-3):11-7. PubMed ID: 7514089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PSA and PAP as immunohistochemical markers in prostate cancer.
    Epstein JI
    Urol Clin North Am; 1993 Nov; 20(4):757-70. PubMed ID: 7505984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and characterization of propagable cell lines (HUNC) from the androgen-sensitive Dunning R3327H rat prostatic adenocarcinoma.
    Presnell SC; Borchert KM; Glover WJ; Gregory CW; Mohler JL; Smith GJ
    Carcinogenesis; 1998 Apr; 19(4):585-90. PubMed ID: 9600341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Determination of prostatic specific antigen and prostatic acid phosphatase as tumor markers of cancer of the prostate].
    Morote Robles J; de Torres Mateos JA
    Arch Esp Urol; 1989; 42 Suppl 2():124-30. PubMed ID: 2484148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in immunohistochemical staining in prostatic adenocarcinoma following diethylstilbestrol therapy.
    Grignon D; Troster M
    Prostate; 1985; 7(2):195-202. PubMed ID: 2413432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.